ALKBH5 and familial pancreatic carcinoma: As mentioned before, upregulation of ALKBH5 or IGF2BP2 were both significantly associated with poor survival in several studies, highlighting the prognostic value of ALKBH5 and IGF2BP2 in pancreatic cancer.